Co-Investigator for OASIS-6 Study: An International randomised study evaluating the efficacy and safety of Fondaparinox Sodium versus control therapy and Glucose Insulin Potassium infusion versus control in a broad range of patients with ST segment elevation acute myocardial infarction
Co-Investigator for RE-LY Study. Randomised Evaluation of Long term anticoagulant therapy (RE-LY) comparing the efficacy and safety of two blinded doses of Debigatarn Elexilate with open label Warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, parallel group, non-inferiority trial
Thrombo Embolic and Haemorrhagic Complications in Patients Receiving Oral Anti Coagulants Following Mechanical Prosthetic Valve Replacement. Cardiological Society of India (CSI) National Conference, Mumbai. 1988
C-Reactive and Its Correlation with Severity of Artery Disease. Cardiological Society of India (CSI) National Conference, Hyderabad. 2001
Risk Factors for Coronary Artery Disease and Correlation of Severity with Angiography. Cardiological Society of India (CSI) National Conference, Bangalore. 2004
Tissue Doppler Imaging Study of Atrial Fibrillation Cycle Length during Amiodarone Therapy. Cardiological Society of India (CSI) National Conference, Bangalore. 2004
CT Image of Femoral Pseudo Aneurysm. Indian Heart Journal. 2007
Left Main Primary Angioplasty in Left Dominant System. NIC Midterm Conference, Kolkata. 2012. India Live Conference, Chennai. 2013
Left Main Primary Angioplasty in Left Dominant System. EURO PCR. Paris, France. Apr 2013
Your participation in the survey will help other patients make informed decisions. You will also be helping Dr.P.P. Mohammed Musthafa and his staff know how they are doing and how they can improve their services.
How was your experience with Dr.P.P. Mohammed Musthafa?
Help other patients, and let the doctor know how he's doing